$14.52 −1.6% from the 52-week high of $14.76 · +163.5% from the 52-week low of $5.51
This analysis is based on closing-price data as of October 2, 2026. Whether you're researching how to buy Amplitude, Inc. stock or you've just opened a brokerage account and are trying to time an entry, here are objective support levels and stop-loss references built from the RSI, MACD and ATR indicators.
After a long slide into a spring 2026 low near $5.51, Amplitude turned sharply in July and has since more than doubled; the October 2 close of $14.52 is the highest close on the two-year chart and sits 1.6% under the $14.76 intraday 52-week high. Mansfield relative strength is +39.0% vs the Nasdaq Composite and accelerating. The short-term trigger is a breakout out of a five-week range: the first close above the prior 20-day high came on September 30, the same day Piper Sandler raised its price target on the stock, and the move was then extended on two sessions without a known event. Against that, RSI shows a bearish divergence against the late-August peak and ADX says the trend leg is not yet strong, so this page reads the setup as a range breakout that still has to prove it can hold.
| Close | $14.52 |
|---|---|
| 52-week high / low | $14.76 (−1.6%) / $5.51 (+163.5%) |
| SMA5 / SMA20 / SMA60 | $13.92 / $13.37 / $11.91 — close > SMA5 > SMA20 > SMA60, bullish alignment |
| Bollinger (20) | Upper $14.53 · Mid $13.37 · Lower $12.21 · width 17.31% — close pressing the upper band |
| aVWAP — 90d | $11.30 (anchor Jul 1, 2026) — price above |
| aVWAP — 2y | $9.35 (anchor May 7, 2026) — price above |
| RSI (14) | 65.0 — firm, below 70 · bearish divergence flagged (2y and 90d) |
| Mansfield RS | +39.0% vs the Nasdaq Composite · outperform · slope rising · prior week 28.08 · prior month 32.48 |
| MACD (12,26,9) | MACD 0.429 · Signal 0.400 · Histogram +0.029 · golden cross Oct 2, 2026 (above zero) |
| ADX (14) | 19.4 (2y) / 19.7 (90d) — ranging, below 20 (direction-neutral) |
| ATR (14) | $0.67 — 4.6% of price |
| OBV — 2y / 90d | Early accumulation, above MA20, slope flat in both frames · spread vs own MA20: 33.24% (2y) / 24.01% (90d) · no OBV divergence flagged in either frame |
| Volume | 1,727,200 shares — 1.07× the 20-day average of 1,610,140 (about 1.23× after adjusting for a quiet 0.875× market session) |
| Stop references | 1×ATR $13.85 (−4.6%) · 2×ATR $13.18 (−9.2%) |
The two-year picture has three acts: a choppy range between roughly $8 and $14 through 2025, a steep decline in early 2026 that set the 52-week low of $5.51, and a reversal that began in July. The July 23 close of $8.05 is the low of the current up-swing; from there the stock climbed to a $14.30 close on August 28 (the intraday 52-week high of $14.76 printed that day), then spent five weeks in a range of roughly $12.39 to $14.30 while the shorter averages caught up. The October 2 close of $14.52 is the first close above that range and the highest close on the two-year chart (the February 2025 peak topped out at a $14.44 close, with an intraday high of $14.88).
The moving averages are fully stacked: close $14.52 above SMA5 $13.92, SMA20 $13.37 and SMA60 $11.91. SMA20 has been above SMA60 since June 5, the close has held above SMA60 since late June, and the full SMA5 > SMA20 > SMA60 order has been in place since September 17 — so the trend predates the breakout. The first close above the prior 20-day high came on September 30 ($13.85, +1.54%), which was the day Piper Sandler raised its price target to $18 from $13 (Overweight); that breakout session should not be read as independent of the analyst note. The price reaction that day was small, and the following two sessions — October 1 (+3.25%, to a $14.30 close that matched the August peak) and October 2 (+1.54%) — carried no identified event. The close now sits right at the upper Bollinger Band ($14.53) with a 17.31% band width. Both anchored VWAPs are well below: $11.30 on the 90-day frame and $9.35 on the two-year frame.
Base-date volume was 1,727,200 shares, 1.07× the 20-day average of 1,610,140. October 2 was a quiet session for the market as a whole — the median stock in our universe traded at about 0.875× its own 20-day average — so on a market-adjusted basis AMPL's participation was closer to 1.23×.
The heaviest bar of the breakout is September 30, the analyst-note day, at roughly twice the 20-day average. The two follow-through sessions ran near normal volume (about 0.88× on October 1 and about 1.08× on October 2). That pattern cuts both ways: the extension did not depend on another burst of buying, but it also was not accompanied by the kind of volume expansion that marks heavy accumulation. The 20-day average itself has drifted lower since August, which is typical of a consolidation. A raw ratio near 1× is the "adequate, not emphatic" zone — no shrinking-volume breakout, but no conviction surge either.
MACD (0.429) crossed above its signal line (0.400) on October 2, turning the histogram positive at +0.029. This is a re-cross above zero: MACD peaked above 1.1 in late August, declined through September as price moved sideways, and has now turned back up without ever dropping below zero. That is the usual shape of a trend resuming after a pause rather than a new trend starting.
The cross is one session old and the histogram is barely positive, so it is fragile. MACD is also well below its August peak — momentum has improved but has not regained the strength of the summer advance. A histogram that keeps widening over the next week would support the breakout; a quick fold back under the signal line would mark the cross as noise from a narrow range.
RSI stands at 65.0 — firm, below the 70 overbought line. The chart flags a bearish RSI divergence in both frames: on August 28 the close was $14.30 with RSI at 76.8 (90-day; 76.7 on the two-year frame), while on October 2 the close was a higher $14.52 with RSI at a lower 65.0. Price made a higher closing high; momentum did not.
The gap between the two RSI peaks is wide — roughly twelve points — which makes this divergence more noticeable than a marginal one. Part of it is mechanical: the August peak came at the end of a near-vertical run, while the October high comes out of a sideways range, and RSI naturally reads lower after a range. Still, a divergence is a possibility of a turn, not a confirmation. A push back through 70 on the next leg would weaken it; a roll-over below 50 would give it teeth.
Mansfield RS is +39.0% vs the Nasdaq Composite, tagged outperform with a rising slope, and it reads the same in both frames. Against the prior readings it is positive and accelerating: up 10.92 points from last week's 28.08 and up 6.52 points from last month's 32.48. The panel shows RS climbing out of deeply negative territory (near −40 in June) to cross zero in early August, then holding in a roughly 25–40 band through September.
This is the strongest structural argument on the page. The stock has been outperforming its benchmark by a wide margin for two months, held that lead through the September consolidation, and widened it again this week. Relative strength is a large part of why AMPL appears in this week's breakout screen (RS rank 96).
ATR is $0.67, or 4.6% of price — a wide daily range for a stock at this level, and near the top of its 90-day reading. That sets the objective stop references at $13.85 (1×ATR, −4.6%) and $13.18 (2×ATR, −9.2%). The 2×ATR level sits just below SMA20 ($13.37) and inside the September range, so a close there would mean the breakout has failed back into the consolidation.
ADX is 19.4 on the two-year frame and 19.7 on the 90-day frame, below 20 — the "ranging" zone. It peaked in August and has been declining through the September consolidation without turning up yet. ADX measures strength, not direction; at this level it says the breakout has not yet produced a trending phase. A rise back above 20–25 would confirm that the range has turned into a new trend leg.
OBV is tagged early accumulation in both frames — above its 20-day average with a flat slope. The spread over its own MA20 is 33.24% on the two-year frame and 24.01% on the 90-day frame; that spread measures how far OBV sits above its average, not a divergence. Neither frame flags an OBV divergence.
On the 90-day panel OBV went sideways through September along with price and has lifted over the last three sessions to the top of that band. So unlike RSI, cumulative volume is broadly keeping pace with the price breakout. "Flat" slope means the accumulation tag is early rather than established; a sustained rise in OBV over the next week would turn this from a supportive reading into a confirming one.
| Scenario | Probability | Path | Trigger / Invalidation |
|---|---|---|---|
| Breakout extends | 40% | Price clears the $14.76 intraday 52-week high and ADX turns up out of the ranging zone. | Trigger: closes above $14.76 on volume above the 1,610,140 average, RSI back through 70. Invalidation: close back below $14.30. |
| Retest of the range top | 35% | The stretch at the upper band unwinds toward the $14.30 former range top or SMA5 ($13.92) before the trend resumes. | Holds above SMA20 $13.37 on the pullback; MACD stays above its signal. |
| Failed breakout | 25% | The move fades back into the September range and the RSI divergence plays out. | Close below the 2×ATR stop $13.18; MACD folds back under its signal. |
| Price | Role | Basis |
|---|---|---|
| $14.76 | Resistance | 52-week high (intraday, Aug 28, 2026) |
| $14.52 | Current | Close of Oct 2, 2026 · just under the upper Bollinger Band $14.53 |
| $14.30 | Support | Aug 28 closing peak · 0% of the $8.05 → $14.30 up-swing (former range top) |
| $13.92 | Support | SMA5 |
| $13.37 | Support | SMA20 / Bollinger mid-band |
| $13.18 | Stop (2×ATR) | Objective invalidation, −9.2% from the close |
| $12.83 | Support | 23.6% retracement of the $8.05 → $14.30 swing (Jul 23 → Aug 28) |
Deeper references: the 38.2% retracement at $11.91 coincides with SMA60 ($11.91), the 50% retracement is $11.18, and one unfilled support gap remains at $8.91–$9.10 (August 3, 2026) — two-year context rather than levels relevant to the next two weeks.
This analysis is an educational interpretation of chart data and is not investment advice. Probabilities and levels are subjective estimates; every investment decision, and its outcome, is your own responsibility. All figures are derived from closing-price data through October 2, 2026 and are not updated after publication.
Two Week Swing · twoweekswing.com · 4,600+ stocks screened weekly